American Journal of Biochemistry

p-ISSN: 2163-3010    e-ISSN: 2163-3029

2024;  14(2): 9-16

doi:10.5923/j.ajb.20241402.01

Received: Sep. 23, 2024; Accepted: Oct. 16, 2024; Published: Oct. 31, 2024

 

Assessment of Lipid Profile in Homozygous Sickle Cell Subjects (SS) According to Physical Activity

Thioune Ndèye Marème1, Kandji Pape Matar1, 2, Djite Moustapha1, 2, Barry Nene Oumou Kesso1, 2, Ndiougue Faye3, Ndour El Hadji Malick2, Gueye-Tall Fatou2, Mor Diaw4, Macoura Gadji3, Lopez-Sall Philomene2, Cisse Aynina2, Diop Pape Amadou2, Gueye Papa Madieye1, 2

1Laboratory of Biochemistry-Hematology, National University Hospital of Fann, Dakar, Senegal

2Laboratory of Pharmaceutical Biochemistry, Faculty of Medicine, Pharmacy, Cheikh Anta Diop University, Dakar, Senegal

3Laboratory of Hematology, Faculty of Medicine, Pharmacy of the Cheikh Anta DIOP University of Dakar

4Laboratory of Physiology and Functional Explorations of the Cheikh Anta DIOP University of Dakar

Correspondence to: Thioune Ndèye Marème, Laboratory of Biochemistry-Hematology, National University Hospital of Fann, Dakar, Senegal.

Email:

Copyright © 2024 The Author(s). Published by Scientific & Academic Publishing.

This work is licensed under the Creative Commons Attribution International License (CC BY).
http://creativecommons.org/licenses/by/4.0/

Abstract

Homozygous sickle cell disease (SS) is characterized by a disturbance in lipid balance parameters and a risk of cardiovascular disease. Physical activity, which has long been considered a high-risk situation for sickle-cell patients, could be a means of preventing CVD. The overall aim of this study was to assess the impact of regular physical activity on lipid parameters in homozygous sickle cell subjects (SS). This was a case-control study; carried out at the biochemistry laboratory of CHNU/FANN in the period from 01 March 2021 to 30 June 2022. All SS sickle cell patients followed at the CNTS were included. Each subject was associated with a control of the same sex and age ±2 years. The physical activity or inactivity levels of our subjects were assessed with a questionnaire (GPAQWHO) and an accelerometer watch. Lipid parameters were determined using the ARCHITECT® ci4000 automaton, and the three ratios CT/HDL-c, LDL/HDL-c and log TG/HDL-c were calculated. The study included 55 homozygous sickle cell (SS) patients. Mean age was 29 years. Evaluation of mean lipid parameters in active and sedentary sickle cell patients revealed mean values of 0.99(g/l), 1.04; (g/l) for total cholesterol; 0.41(g/l), 0.35(g/l) for HDL-c; 0.52(g/l), 0.57(g/l) for LDL-c and 0.65(g/l), 0.79 (g/l) for triglycerides, respectively. Comparison of mean lipid parameters between these two groups showed no statistically significant difference. Comparison of the three indices showed a statistically significant difference (p = 0.025) for Log(TG/HDL-c). Atherogenic risk was higher in sedentary sickle-cell patients, with a frequency of 66%. These results suggest that regular physical activity can help prevent cardiovascular disease in SS homozygous sickle cell patients.

Keywords: Physical activity, Sickle cell disease, Lipids, Atherogenic risk

Cite this paper: Thioune Ndèye Marème, Kandji Pape Matar, Djite Moustapha, Barry Nene Oumou Kesso, Ndiougue Faye, Ndour El Hadji Malick, Gueye-Tall Fatou, Mor Diaw, Macoura Gadji, Lopez-Sall Philomene, Cisse Aynina, Diop Pape Amadou, Gueye Papa Madieye, Assessment of Lipid Profile in Homozygous Sickle Cell Subjects (SS) According to Physical Activity, American Journal of Biochemistry, Vol. 14 No. 2, 2024, pp. 9-16. doi: 10.5923/j.ajb.20241402.01.

1. Introduction

Sickle cell disease is an autosomal recessive inherited disorder [1]. It is the most widespread hemoglobinopathy in the world, affecting over 270 million people, most of them in sub-Saharan Africa [2]. In Senegal, its prevalence varies from 8 to 10% [3] including 1% for homozygous forms [4]. Sickle cell disease in its homozygous form (SS) is characterized by a number of complications, including chronic hemolytic anemia, abdominal pain, vaso-occlusive crises (CVO), acute chest syndrome (ACS) and disturbances of lipid parameters, which can be disabling or even fatal [5]. Management of patients with sickle cell disease has improved steadily over the last few decades. This improvement is accompanied by a better quality of life for the patient and reduced morbidity [6]. However, exercise is considered a high-risk situation for the sickle cell patient, and clinical practice recommends reduced physical activity for these subjects. The mechanisms identified as deleterious for sickle-cell patients and which may be associated with physical exercise are those linked to a reduction in PaO2 [7]. However, in the non-sickle-cell population, regular physical activity (not necessarily intense) helps maintain efficient vascular function [8,9]. This could therefore be a means of preventing some of the cardiovascular complications observed in sickle-cell patients. Studies have already suggested assessing the level of physical activity in sickle cell patients [7,10]. However, none of these studies have examined the clinical/biological manifestations of sickle cell disease in relation to the intensity of physical activity. Thus, the general objective of this work was to evaluate the impact of physical activity on lipid balance parameters in homozygous sickle cell subjects (SS).

2. Materials and Methods

This was a prospective, descriptive and analytical case-control study, lasting sixteen months from 01 March 2021 to 30 June 2022. Subjects were recruited at the Centre National de Transfusion Sanguine (CNTS) and biological tests were performed at the Biochemistry Laboratory of the Centre Hospitalier National Universitaire de Fann.
The study involved adult male SS sickle cell patients followed at the CNTS, residing in Senegal and having given their agreement to the study through free and informed consent. The study did not include subjects who had received a transfusion in the previous three months or subjects who had suffered a vaso-occlusive crisis (VOC) or acute chest syndrome (ACS) in the previous three months. For each case, a control (same sex and age ± 2) was chosen from among the blood donors.
Several types of variables were studied in our study population:
- Clinical parameters: acute chest syndrome (ACS), myalgia, leg ulcer, priapism, abdominal pain and stroke.
- Biological parameters: lipid balance parameters (total cholesterol, HDL-cholesterol, LDL-cholesterol, triglycerides) were assessed and plasma atherogenicity indices calculated using the following formulae: (TG/HDL-c; LDL-c/HDL-c et Log (TG/HDL-c).
Blood samples were taken from these patients in the morning, after a 12-hour fast, by venipuncture at the elbow. The blood was collected in a dry tube and centrifuged at 3000 rpm for 5 minutes.
Plasma concentrations of lipid balance parameters were determined using the ARCHITECT® ci4000 automated system (Abbott core laboratory, Illinois, USA). Our subjects' levels of physical activity or inactivity were assessed in two different ways:
- Global Physical Activity Questionnaire (GPAQ, WHO). This questionnaire consists of 16 questions enabling us to assess our subjects' lifestyles [(sedentary or inactive) or active] in different areas of physical activity (occupation, travel, leisure).
- To be much more precise, we used ‘accelerometer’ watches. These are wristwatches that measure the number of steps taken per day, the distance covered, calorie expenditure and the number of active minutes. They also assess hour-by-hour activity and inactivity. Fitbit Alta HR accelerometers from China were used. Our data was recorded using Microsoft EXCEL 2016 software. XLSTAT 2020 was used to analyse the data. The Mann Whitney test was used to compare mean values. The Chi-square test was used to compare frequencies and a p-value of less than 0.05 was considered statistically significant.

3. Results

Our study population consisted of 55 sickle cell subjects (SS profile) and 55 control subjects. The mean age of our subjects was 29 years, with a standard deviation of ±8years and extremes of 18 and 49 years (Table 1).
Table 1. Epidemiological characteristics of the study population
     
The distribution of sickle-cell subjects according to physical activity showed that active sickle- cell patients represented 47% (i.e. 26 subjects) and sedentary sickle-cell patients represented 53% (i.e. 29 subjects) (Figure 1).
Figure 1. Distribution of subjects with sickle cell disease according to physical activity
Among clinical complications, abdominal pain (AD) was the most common, with a frequency of 66% in both active and inactive sickle-cell patients. We found higher frequencies of myalgia and priapism in sedentary sickle cell patients (66% and 21%) (Figure 2).
Figure 2. Assessment of clinical characteristics according to physical activity
We determined the mean plasma concentrations of the various lipid parameters in active sickle cell subjects, sedentary sickle cell subjects and controls.
Table 2. Assessment of lipid balance parameters in the study population
     
A comparative study of mean concentrations of lipid parameters in active and sedentary sickle cell subjects showed no statistically significant difference for any of the parameters studied (figure 3).
Figure 3. Comparison of lipid balance parameters according to physical activity
Comparison of mean concentrations of lipid balance parameters between sedentary sickle cell subjects and controls showed significant differences (p < 0.0001) for total cholesterol, HDL-c and LDL-c (Figure 4).
Figure 4. Comparison of mean concentrations of lipid balance parameters between sedentary sickle-cell subjects and controls
Comparative analysis of mean concentrations of lipid balance parameters between active sickle cell subjects and controls also showed significant differences (p < 0.0001) for all parameters studied, with the exception of triglycerides (Figure 5).
Figure 5. Comparison of mean concentrations of lipid balance parameters between active sickle cell subjects and controls
Comparison of the three indices used in active sickle-cell subjects and sedentary sickle-cell subjects showed a statistically significant difference (p = 0.025) only for Log (TG/HDL-c) (Table 3).
Table 3. Comparison of atherogenicity indices between active and inactive sickle cell subjects
     
Evaluation of the three indices in active sickle-cell subjects and controls showed a statistically significant difference (p = 0.02) only for Log (TG/HDL-c), with a mean value of 0.189 in active sickle-cell subjects versus 0.04 in controls (Table 4).
Table 4. Comparison of atherogenicity indices between active sickle cell subjects and controls
     
Evaluation of the three indices in sedentary sickle cell subjects and controls showed a statistically significant difference (p <0.0001) only for Log (TG/HDL-c) (Table 5).
Table 5. Comparison of atherogenicity indices between sedentary sickle cell subjects and controls
     
The evaluation of plasma atherogenicity index disturbances in our study showed that 66% of sedentary sickle cell patients had a log ratio (TG/HDL-c) greater than 0.21, compared with 42% of active sickle cell patients (Figure 6).
Figure 6. Frequency of sickle cell disease patients with elevated plasma atherogenicity index (PAI) as a function of physical activity

4. Discussion

Sickle cell disease is an autosomal recessive inherited disorder linked to a genetic mutation that results in the production of a pathological hemoglobin called hemoglobin S (HbS) [11]. Homozygous sickle cell disease SS is characterized by painful vaso-occlusive crises, an inflammatory reaction, oxidative stress and a high atherogenic risk [12].
The care of sickle cell patients has steadily improved over the last few decades. This improvement is accompanied by a better quality of life for the sickle cell patient. However, exercise is considered a high-risk situation in sickle cell patients, and clinical practice recommends reduced physical activity for these patients. Yet regular physical activity is a means of preventing cardiovascular disease.
Thus, the general objective of this work was to evaluate the impact of physical activity on lipid balance parameters in homozygous sickle cell subjects (SS).
Analysis of the study population revealed an average age of 29, with extremes of 18 and 49. Our results are similar to those of Diop et al. in a study carried out in Senegal, who found a mean age of 27 years, with extremes of 20 and 51 years [13]. In addition, a recent study of homozygous male sickle cell patients in Senegal by Gaye et al. also found a mean age of 27.1 with a standard deviation of ± 7.1 years [14]. These results could be explained by the major efforts made in Senegal to provide early care for patients from childhood onwards [15] but also by the increased life expectancy of homozygous sickle-cell patients worldwide. Authors have also reported that in the USA, 50% of patients reach the age of 50 [16] and life expectancy for patients in Jamaica has been estimated at 53 years for men [17]. This improvement in life expectancy could be explained by several factors, including earlier diagnosis, the implementation of prophylactic measures, and the increase in the number of specific centers for the care of sickle cell patients.
Clinically, abdominal pain (AP) was the most common complication, with a frequency of 66% in both active and inactive sickle-cell patients. For priapism, we found a frequency (21%) in sedentary sickle cell patients versus (16%) in active sickle cell patients, Gaye et al. had found frequencies (43%) higher than ours [14]. Other studies have shown that the prevalence of priapism in adult sickle-cell patients varies from 9.3% to 42% [18,19].
The higher frequency of priapism in sedentary sickle-cell patients could be explained by a sedentary lifestyle. In most cases, priapism is due to a blood circulation disorder, and physical activity helps improve vascular function. What's more, physical activity (e.g. rapid ascent and descent of stairs, cycling, etc.) is even recommended in cases of priapism, to relieve the pain [20].
Evaluation of the lipid profile in the sickle-cell subjects in the study population revealed a reduction in total cholesterol levels, as well as in HDL-c and LDL-c fractions. Comparison of mean lipid parameters between sickle cell patients and controls showed statistically significant differences (p<0.05). This hypocholesterolemia is corroborated by several studies, including that of Guarda et al. who found mean concentrations of 1.18g/l for total cholesterol, 0.40 g/l HDL-c and 0.58 LDL-c. These values are similar to ours [21]. The same is true of Gueye et al. in Dakar [22] and Mondé et al. in Côte d'Ivoire [23] who found results comparable to ours.
In fact, this hypocholesterolemia could be explained by an increase in plasma volume due to a reduction in packed red blood cells. The increase in plasma volume is greater and more frequent in sickle-cell subjects than in other anemic states. Similarly, reduced endogenous cholesterol synthesis may be at the root of this hypocholesterolemia [24,25] as well as the possibility of membrane lipoperoxidation of cholesterol, with secondary mobilization of plasma cholesterol to the erythrocyte membrane, resulting in a decrease in plasma cholesterol [26,27]. On the other hand, the decrease in the LDL-c fraction could be due to inflammation associated with oxidative stress and increased lipoperoxidation. The LDL-c level would not reflect the real situation in homozygous sickle-cell patients due to oxidative stress, which would transform part of the LDL into oxidized LDL.
Evaluation of triglyceridemia had shown a higher mean concentration (0.79g/l) in sedentary sickle cell patients compared with active sickle cell patients (0.65 g/l) and controls (0.67 g/l). Similar results were reported in the study by Monnet et al. [28]. This rise in triglycerides could be explained by the increased production of endogenous lipids (VLDL) and the decrease in lipoprotein lipase activity caused by oxidative stress [29].
A comparative study of mean concentrations of lipid balance parameters between active and sedentary sickle cell patients showed no statistically significant difference for any of the parameters studied. On the other hand, we obtained a higher mean HDL-c concentration in active sickle-cell patients, associated with a lower mean LDL-c and triglyceride concentration. This could be explained by physical activity, which, according to several studies, helps combat cardiovascular risk factors (CRFs) by lowering LDL-cholesterol (by 5%) and triglycerides (by 3.7%), and increasing HDL-cholesterol (vasculo-protective, by 4.6%) [30,31].
To assess atherogenic risk in our study population, atherogenicity indices were determined using different formulas: the TC/HDL-c ratio, the LDL-c/HDL-c ratio and the logarithm of the TG/HDL-c ratio, also known as the plasma atherogenicity index (PAI). Comparison of mean index values between active, sedentary sickle-cell patients and controls showed a significant difference with a p<0.05 only for the logarithm of the TG/HDL-c ratio. Our results are similar to those reported by Mondé et al. who also found no significant difference between stationary sickle cell patients and controls for these two indices (the TC/HDL-c ratio and the LDL-c/HDL- c ratio) [23].
Comparison of the three indices used in active and sedentary sickle-cell subjects showed a statistically significant difference (p = 0.025) only for Log (TG/HDL-c), with a value of 0.189 in active sickle-cell subjects versus 0.334 in inactive sickle-cell subjects. Furthermore, atherogenic risk assessment in our study showed that 66% of sedentary sickle cell patients had a log ratio (TG/HDL-c) greater than 0.21, compared with 42% of active sickle cell patients. A study by Mudhaffar et al. found a higher frequency ((84%); IAP>0.21) than ours [32]. Other studies have been carried out along these lines, notably that of Gasiano et al. who reported that DPI is a strong predictor of cardiovascular disease and can be successfully used to assess atherogenic risk [33].
In our study population, the atherogenic risk was higher in sedentary sickle cell patients, which could be explained by the lack of physical activity. Studies have reported that regular physical activity, such as slow or moderate running or, failing that, walking for a relatively long time (around 45 to 60 min), repeated three times a week, can considerably modify atherogenic blood lipid levels and reasonably increase anti-atherogenic blood lipid levels [34,35]. Regular aerobic exercise therefore theoretically has the potential to induce significant weight loss and, consequently, to favourably modify atherogenic lipid levels [36].

5. Conclusions

Homozygous sickle cell disease SS is characterized by painful vaso-occlusive crises, an inflammatory reaction, oxidative stress, disturbed lipid balance parameters and a risk of developing cardiovascular disease.
Improved management of sickle cell patients is accompanied by a better quality of life. Regular physical activity is seen as a means of preventing cardiovascular disease.
Thus, the general objective of this work was to evaluate the impact of physical activity on lipid balance parameters in homozygous sickle cell subjects (SS).
At the end of this study, we found a higher atherogenic risk in sedentary sickle cell patients, which could be linked to a sedentary lifestyle. These results suggest that physical activity could be a means of preventing cardiovascular disease in sickle-cell patients.
A longitudinal study of sedentary sickle cell patients is currently underway, which will enable us to assess the impact of a gradual increase in the intensity of daily physical activity on clinical and biological parameters.

ACKNOWLEDGEMENTS

We would like to thank all those who took part in this study.

CONFLICT OF INTERESTS

The authors have not declared any conflict of interest.

CONSENT

Written and informed consent was obtained from each participant.

References

[1]  Moynot S, Moynot JC, Commandeur D, Danguy M, Montelescaut E, Kenane N, et al. Sickle cell disease: from molecular aspects to clinical practice. A case report and a literature analysis. Ann Biol Clin (Paris). 2011; 69(6): 679-84. DOI:10.1684/abc.2011.0633.
[2]  Bandeira FMGC, Bezerra MAC, Santos MNN, Gomes YM, Araújo AS, Abath FGC. Importância dos programas de triagem para o gene da hemoglobina S. Rev Bras Hematol Hemoter Hemoter 2007; 29: 179-84. DOI https://doi.org/10.1590/S1516-84842007000200017.
[3]  Diop S, Sene A, Cisse M, Toure AO, Sow O, Thiam D, et al. Pre- valence and morbidity of G6PD deficiency in sickle cell disease in the homozygote. Dakar Med 2005; 50:56-60. https://europepmc.org/article/MED/16295757.
[4]  Diagne I, Ndiaye O, Moreira C, Signate -Sy H, Camara B. Major sickle cell syndromes in Dakar (Senegal) Arch Pediatr, 2000; 7(1): 16-24.
[5]  Connes P, Machado R, Hue O, Reid H.Exercise limitation, exercise testing and exercise recommendations in sickle cell anemia. Clin Hemorheol Microcirc. 2011; 49(1-4): 151-63. DOI: 10.3233/CH-2011-1465.
[6]  Gomes E, Castetbon K, Goulet V. Sickle cell disease mortality in France: age of death and associated causes (1979-2010). Bull Epidémiol Hebd. 2015; (8): 142-50. https://www.researchgate.net/publication/273768250.
[7]  Halphen I, Elie C, Brousse V, Le Bourgeois M, Allali S, Bonnet D, et al. Severe nocturnal and postexercise hypoxia in children and adolescents with sickle cell disease. PloS One. 2014; 9(5): e97462. https://doi.org/10.1371/journal.pone.0097462.
[8]  Warburton D, Nicol CW, Bredin SSD.Health benefits of physical activity: the evidence. CMAJ Can Med Assoc J J Assoc Medicale Can. 2006; 174(6): 801-9. DOI: https://doi.org/10.1503/cmaj.051351.
[9]  Haskell WL, Lee IM, Pate RR, Powell KE, Blair SN, Franklin BA, et al. Physical activity and public health: updated recommendation for adults from the American College of Sports Medicine and the American Heart Association. Med Sci Sports Exerc. 2007; 39(8): 1423-34. DOI: 10.1249/mss.0b013e3180616b27.
[10]  Liem RI, Reddy M, Pelligra SA, Savant AP, Fernhall B, Rodeghier M, et al. Reduced fitness and abnormal cardiopulmonary responses to maximal exercise testing in children and young adults with sickle cell anemia. Physiol Rep. 2015; 3(4): e12338. DOI: 10.14814/phy2.12338.
[11]  Okpala I, Tawil A.Management of pain in sickle cell disease. J R Soc Med 2002; 95: 456-8. DOI: 10.14814/phy2.12338.
[12]  Monnet PD, Kane F, Konan D, Akpona S, Kora J, Diafouka F, et al. Assessment of atherogenic risk in homozygous sickle cell disease. Bull Soc Path Ex 1996; 89: 278-81.
[13]  Diop S, Mokono SO, Ndiaye M, Touré Fall AO, Thiam D, Diakhaté L. Homozygous sickle cell disease after the age of 20: follow-up of a cohort of 108 patients at Dakar University Hospital. Rev Médecine Interne. Nov 2003; 24(11): 711-5. DOI: 10.1016/s0248-8663(03)00220-0.
[14]  Gaye O, Seck M, Gueye SM, Touré SA, Diallo AI, Faye BF, et al. Evaluation of sexuality in homozygous adult sickle cell disease patients with a history of priapism in Senegal. Prog En Urol. 2022; S1166708722000987. https://doi.org/10.1016/j.purol.2022.03.008.
[15]  Diop S, Diop D, Seck M, Guèye Y, Faye A, Dièye TN et al. Predictive factors for chronic complications of homozygous sickle cell disease in adults in Dakar (Senegal). Med Trop. 2010; 70: 471-474. https://pubmed.ncbi.nlm.nih.gov/21520649/.
[16]  Platt OS, Brambilla DJ, Rosse WF, Milner PF, Castro O, Steinberg MH, et al. Mortality in sickle cell disease. Life expectancy and risk factors for early death. N Engl J Med. 1994; 330(23): 1639-44. DOI: 10.1056/NEJM199406093302303.
[17]  Wierenga KJ, Hambleton IR, Lewis NA.Survival estimates for patients with homozygous sickle-cell disease in Jamaica: a clinic-based population study. Lancet Lond Engl. 2001; 357(9257): 680-3. DOI: 10.1016/s0140-6736(00)04132-5.
[18]  Emond AM, Holman R, Hayes RJ, Serjeant GR. Priapism and impotence in homozygous sickle cell disease. Arch Intern Med. 1980; 140(11): 1434-7. https://pubmed.ncbi.nlm.nih.gov/6159833/.
[19]  Wallois A, Vian E, Loko G, Blanchet P. Evaluation of sexuality in Afro-Caribbean SS homozygous sickle cell patients followed in Martinique. Prog En Urol. 2012; 22(5): 301-6. DOI: 10.1016/j.purol.2011.09.015.
[20]  Maiorino MI, Bellastella G, Esposito K. Lifestyle modifications and erectile dysfunction: what can be expected? Asian J Androl. 2015; 17(1): 5-10. DOI: 10.4103/1008-682X.137687.
[21]  Guarda CC, Yahouédéhou SCMA, Santiago RP, Fernandes CF de L, Neres JS dos S, Oliveira AM de J, et al. Investigation of Lipid Profile and Clinical Manifestations in SCA Children. Dis Markers. August 20, 2020; 2020: 1-10. DOI:10.1155/2020/8842362.
[22]  Tall FG, Ndour E, Cisse F, Gueye PM, Diatta A, Ndiaye RN. et al. Perturbations of lipid parameters during sickle cell disease. Rev Afr Malgache Rech Sci Santé. 2014 [cited August 7, 2022]; 2(2). Available from: http://publication.lecames.org/ index.php/sante/article/view/383.
[23]  Mondé AA, Kouamé-Koutouan A, Tiahou GG, Camara CM, Yapo AA, Djessou SP, et al. Lipidoprotein profile, isotope and atherogenic risk in sickle cell disease in Côte d'Ivoire. Médecine Nucl. 2010; 34: e17-21. https://doi.org/10.1016/j.mednuc.2010.07.015.
[24]  VanderJagt DJ.Hypocholesterolemia in Nigerian Children with Sickle Cell Disease. J Trop Pediatr. June 1, 2002; 48(3): 156-61. DOI: 10.1093/tropej/48.3.156.
[25]  Rahimi Z, Merat A, Haghshenass M, Madani H, Rezaei M, Nagel RL. Plasma lipids in Iranians with sickle cell disease: hypocholesterolemia in sickle cell anemia and increase of HDL-cholesterol in sickle cell trait. Clin Chim Acta Int J Clin Chem. 2006; 365(1-2): 217-20. DOI: 10.1016/j.cca.2005.08.022.
[26]  Sess ED, Carbonneau MA, Meite M, Peuchant E, Dumont MF. Lipoperoxidation markers (Lpo), inflammatory proteins and plasma tocopherols in homozygous and heterozygous sickle cell disease. Bull Soc Path Ex 1998; 91: 238-41. https://pubmed.ncbi.nlm.nih.gov/9773200/.
[27]  Belcher JD, Marker PH, Geiger P, Girotti AW, Steinberg MH, Hebbel RP, et al.Low-density lipoprotein susceptibility to oxidation and cytotoxicity to endothelium in sickle cell anemia. J Lab Clin Med. June 1999; 133(6): 605-12. DOI: 10.1016/s0022-2143(99)90191-9.
[28]  Monnet D, Edjeme NE, Ndri K, Hauhouot ML, Ahibo H, Sangare A, et al. Lipoprotein (a) and proteins of the acute phase of inflammation during homozygous sickle cell crisis. Ann Biol Clin (Paris). 2002; 60(1): 101-3. https://pubmed.ncbi.nlm.nih.gov/11830401/.
[29]  Lazarevic MB, Vitic J, Mladenovic V, Myones BL, Skosey JL, Swedler WI. Dyslipoproteinemia in the course of active rheumatoid arthritis. Semin Arthritis Rheum. 1992; 22(3): 172-8. DOI: 10.1016/0049-0172(92)90017-8.
[30]  André P, Six M, Grison C, Metron D.Interest of adapted physical activity for the correction of cardiovascular risk factors in the coronary subject. Kinesitherapy Rev. 2013; 13(135): 23-8. https://doi.org/10.1016/j.kine.2012.12.070.
[31]  Leon AS, Sanchez OA.Response of blood lipids to exercise training alone or combined with dietary intervention: Med Sci Sports Exerc. 2001; 33 (Supplement): S502- 15. DOI: 10.1097/00005768-200106001-00021.
[32]  Mudhaffar SM. Atherogenic Index of Plasma (AIP) As a Parameter in Predicting Cardiovascular Risk in Males Compared To the Conventional Dyslipidemic Indices (Cholesterol Ratios). Karbala J. Med. 2013; 6(1): 91. https://www.researchgate.net/publication/269964677_Atherogenic_index_of_plasma_Atherogenic_ index_of_plasma_AIP_as_a_parameter_in_predicting_cardiovascular_risk_in_males_compared_to_ the_conventional_dyslipidemic_indices_cholesterol_ratios.
[33]  Gaziano JM, Hennekens CH, O'Donnell CJ, Breslow JL, Buring JE. Fasting triglycerides, high- density lipoprotein, and risk of myocardial infarction. Circulation. 1997; 96(8): 2520- 5.
[34]  Fox EL, Mathews DK. Exercise, body composition and weight control. In: Bases physiologiques de l'activité physique. Paris: Vigot, 1984: 339-61.
[35]  Choo J, Elci OU, Yang K, Turk MW, Styn MA, Sereika SM, et al. Longitudinal relationship between physical activity and cardiometabolic factors in overweight and obese adults. Eur J Appl Physiol. 2010; 108(2): 329-36.
[36]  Dansou P, Tolly PLM, Yèhouénou B, Tossou R, Hadonou ML. Practice of maintenance soccer and atherogenic blood lipid levels in obese subjects. Cah Détudes Rech Francoph Santé. 2001; 10(6): 393-7.